CB-2202

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCB-2202

Drug Alias NameCB-2202

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMonoamine oxidase A inhibitors

TargetsMonoamine oxidase A

Therapy Area/IndicationsDepressive Disorder, Major

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesCennerv Pharma

China Registration ClassN/A

Active CompaniesCennerv Pharma

Inactive CompaniesN/A

Active IndicationsDepressive Disorder, Major

Inactive IndicationsN/A

ATC CodeN/A